Group 1 - The report highlights that the new consumption sector performed well, with service consumption policies expected to continue catalyzing growth in 2026 [2][27] - In 2025, the overall performance of the optional consumption sector was weak, but sub-sectors like new consumption showed significant gains, particularly in the first half of the year [16][21] - The retail sales of consumer goods grew moderately, with service retail growth outpacing that of goods retail, indicating a shift towards service consumption [21][27] Group 2 - The tourism sector is expected to benefit from extended holiday periods and improved vacation policies, with companies like Trip.com and Tongcheng Travel being key focuses [3] - The hotel market is showing signs of recovery, with a narrowing decline in RevPAR and increasing leisure demand, highlighting companies like Jin Jiang Hotels and Huazhu Group [3] - The duty-free sector is experiencing a boost from new policies, particularly in Hainan, with a focus on high-end consumption recovery [3] Group 3 - The cosmetics industry saw a slight growth of 6.18% in 2025, with domestic brands continuing to gain market share [4][30] - The medical beauty market is projected to reach approximately 366.6 billion in 2025, with a K-shaped consumption differentiation emerging [4][30] - Innovations in core ingredients and the integration of biotechnology are driving brand growth in the cosmetics sector [4][36] Group 4 - The IP derivative market is expanding due to a flourishing supply of IP and commercial operations, with domestic policies expected to further mature the industry ecosystem [5] - Key players in the IP space include Shanghai Film, Light Media, and Pop Mart, with a focus on both domestic and international market expansion [5] Group 5 - The gold and jewelry sector saw a cumulative growth of 12.78% in retail sales from January to December, with a focus on brand premium capabilities and international expansion [6][9] - The rise of "self-wearing" scenarios is driving gold jewelry sales, with brands like Chao Hong Ji and Lao Pu Gold being highlighted for their international strategies [9]

Investment Rating - The industry maintains a "Recommended" rating, with a focus on service consumption, beauty care, IP derivatives, and gold jewelry as new consumption sectors [6][30]. Core Insights - The total retail sales of social consumer goods in 2025 reached 50.12 trillion yuan, a year-on-year increase of 3.69%. In December, the retail sales totaled 4.51 trillion yuan, growing by 0.9% year-on-year, which was below the consensus expectation of 1.5% [3][24]. - The report highlights significant growth in specific retail categories, with home appliance retail sales increasing by 11%, and retail sales of communication equipment, cultural and office supplies, and furniture growing by 20.9%, 17.3%, and 14.6% respectively [3][24]. - The beauty care sector is seeing innovation, with Proya launching a new PROYA MED series aimed at specific skin repair needs, and Langzi Co. forecasting a net profit of 2.2 to 2.9 billion yuan for 2025, marking a year-on-year increase of 1.09% to 33.25% [27][28]. Summary by Sections Market Performance - From January 19 to January 23, 2026, the trade retail, social services, and beauty care sectors increased by 2.16%, 3.20%, and 1.98% respectively, ranking 16th, 12th, and 17th among 31 primary industries [15][18]. Key Industry Data and News - The report notes that the retail sales of consumer goods in 2025 were driven by the replacement of old appliances, with significant growth in various categories, including a 15.7% increase in sports and entertainment products [3][24]. - The beauty care sector is highlighted with new product launches and positive earnings forecasts from companies like Langzi and Meili Tianyuan, which expects a revenue of at least 30 billion yuan in 2025, growing by no less than 16% [27][28]. Investment Recommendations - The report suggests focusing on companies such as Ruoyu Chen, Mao Ge Ping, Shangmei Co., Pop Mart, Chao Hong Ji, and Lao Pu Gold as potential investment targets within the recommended sectors [6][30].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][29]. Core Insights - The Central Economic Work Conference prioritized domestic demand, emphasizing the need to build a strong domestic market and implement measures to boost consumption [3][23]. - In November 2025, the Consumer Price Index (CPI) saw a year-on-year increase of 0.7%, with the core CPI rising by 1.2% [3][23]. - The report highlights significant investments in the beauty care sector, including Proya's acquisition of a stake in Beijing Huaguan Biotechnology and L'Oréal increasing its stake in Galderma to 20% [3][23][29]. Market Performance - During the week of December 8-12, 2025, the retail, social services, and beauty care sectors experienced declines of 0.21%, 0.76%, and 1.64% respectively [14][15]. - Notably, the education and general retail sub-sectors saw increases of 1.58% and 1.37% [15][18]. Key Industry Events and News - The National Retail Innovation Development Conference emphasized a shift towards quality-driven and service-driven retail, aiming for high-quality development [4][27]. - The report notes a significant increase in card trading on platforms like Xianyu, with a 21% year-on-year growth in trading volume for the first three quarters of 2025 [4][23]. Investment Recommendations - The report recommends specific companies for investment, including Proya, Giant Bio, Marubi, Runben, Chaohongji, and Furuida, focusing on sectors with growth potential [5][29].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][30]. Core Insights - The beauty care sector is seeing significant developments, including L'Oréal's minority stake investment in the Chinese skincare brand LAN and Proya's entry into the PDRN market with a new trademark [3][23]. - E-commerce company Yatsen reported a Q3 revenue of RMB 998 million, a 47.5% year-on-year increase, indicating strong growth in the beauty sector [3][23]. - The report highlights the strategic upgrades of Meili Tianyuan, focusing on brand enhancement, chain expansion, and digital transformation [3][23]. Market Performance - For the week of November 17-21, 2025, the retail, social services, and beauty care sectors experienced declines of 7.24%, 4.86%, and 4.53% respectively, ranking 28th, 15th, and 12th among 31 primary industries [15][16]. - The report notes a general downturn in consumer-focused sub-sectors, with trade, general retail, and tourism experiencing the largest declines of 9.12%, 7.49%, and 5.75% respectively [15][16]. Key Industry Events and News - L'Oréal announced a minority investment in LAN, marking its first investment in a local skincare brand in China [3][23]. - Proya launched a new product line under the "PROYA MED" brand, focusing on scientific and medical attributes [3][23]. - The report mentions significant revenue growth for companies like Yatsen and Meili Tianyuan, with Yatsen's Q3 revenue up 47.5% and Meili Tianyuan announcing strategic upgrades [3][23][24]. Investment Recommendations - The report recommends focusing on companies such as Proya, Giant Bio, Marubi, Runben, and others within the beauty care and new consumption sectors [6][30].

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [2][12]. Core Insights - The company has shown strong revenue growth in FY26H1, with a total revenue of 4.047 billion RMB, representing a year-over-year increase of 32.7% and a half-year increase of 10.8% [5]. - The company is positioned as a leader in the domestic offline ticketing market, with significant IP licensing capabilities, including partnerships with major brands like Sanrio and Chiikawa [12]. - The report highlights the robust growth potential in the live performance and IP sectors, driven by a stable supply of top-tier artists and successful events [6][12]. Financial Performance Summary - **Revenue and Profitability**: In FY26H1, the company achieved a gross profit margin of 35.7%, with a net profit of 520 million RMB, reflecting a year-over-year increase of 54.3% [5]. - **Segment Performance**: The live performance and technology segment generated 1.339 billion RMB in revenue, up 14.5% year-over-year, while the IP derivatives segment saw a remarkable 105.2% increase in revenue, reaching 1.16 billion RMB [6][7]. - **Cost Management**: The company has effectively reduced both sales and management expenses, leading to improved operational efficiency [10]. Future Projections - The company is projected to achieve revenues of 8.107 billion RMB in FY2026, with a net profit forecast of 996 million RMB, indicating a significant growth trajectory [11][12]. - The expected growth rates for revenue and net profit are 21% and 174% respectively for FY2026, showcasing strong financial health and operational performance [12][13].

Core Insights - The company reported a revenue of 4.947 billion yuan for FY26H1, representing a 33% year-on-year increase, primarily driven by strong growth in IP derivative products, particularly from Alibaba Fish [1] - The net profit attributable to shareholders reached 520 million yuan, up 54% year-on-year, due to the excellent performance of Alibaba Fish and a reduction in investment losses [1] - Adjusted EBITA was 550 million yuan, down 14% year-on-year, mainly due to a one-time financial asset impairment reversal of 160 million yuan in the same period last year; excluding this, adjusted EBITA increased by 14% [1] IP Derivative Business - The IP derivative business generated 1.16 billion yuan in FY26H1, a significant increase of 105.31% year-on-year; segment performance was 235 million yuan, up 44.17% [2] - The slower growth in segment performance compared to revenue was attributed to a one-time loss from the shutdown of Jinli Naju during the reporting period [2] - The rapid growth in IP licensing is driven by the continued success of multiple IP matrices, including Sanrio, Chiikawa, Pokémon, and Crayon Shin-chan; the company has also opened several offline themed pop-up and flagship stores in collaboration with upstream copyright holders and trendy toy brands [2] Ticketing and Live Entertainment - The revenue from the company's live content and technology business reached 1.339 billion yuan, a year-on-year increase of 14.54%; segment performance (after deducting costs and sales expenses) was 754 million yuan, up 4.72% [3] - Revenue growth was primarily driven by ticketing business, although growth was somewhat constrained by a slowdown in the supply of live content and limited venue resources; live entertainment content revenue grew by over 50% year-on-year due to the expansion into major concert projects and participation in music festivals, stand-up comedy, and theater [3] Film and Series Production - Revenue from the company's film content and technology business was 1.064 billion yuan, down 15.22% year-on-year; segment performance was 95 million yuan, down 22.76% [3] - Despite the overall pressure in the film market, the company maintained a prudent investment strategy, achieving excellent returns from the film "Chasing the Wind" [3] - The series production business saw a revenue increase of 693.44% to 484 million yuan, with segment performance improving from a loss of 10 million yuan to 38 million yuan, driven by increased investment in high-quality content [3] Profit Forecast and Valuation - Based on the continuous deepening of cooperation in the IP derivative business and the ongoing high growth phase, the profit forecast has been raised, with expected net profits for FY26-FY28 at 915 million, 1.16 billion, and 1.374 billion yuan respectively [4] - The average PE of comparable companies for 2025 is 34X, up from a previous estimate of 26X; given the sustained high demand in the derivative business, a valuation of 36X for FY26 has been assigned, with a target price of 1.21 HKD [4]

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][31]. Core Insights - The report highlights that the overall retail sales in September 2025 reached 4.2 trillion yuan, showing a year-on-year growth of 3.05%, which is below the consensus expectation of 3.1% [21]. - The beauty care sector is experiencing significant activity, with major brands like Proya and Winona showing strong sales performance during the Tmall Double 11 event [24]. - The travel sector is recovering, with nearly 106,000 passenger flights executed in the week of October 20-26, 2025, marking a 2.9% increase year-on-year [4][26]. Market Performance - For the week of October 20-24, 2025, the performance of the retail, social services, and beauty care sectors was +0.46%, +2.60%, and -0.09%, respectively, ranking them 26th, 14th, and 29th among 31 primary industries [13][15]. - The report notes that the trade, education, and professional services sectors performed well, with increases of +4.89%, +3.02%, and +2.70% [15]. Key Company Announcements - Juzi Biotechnology's recombinant type I α1 collagen facial injection has passed the joint review by the medical device and drug regulatory authorities [29]. - Runben Co., Ltd. reported a revenue of 1.238 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 19.28% [29]. - Bubble Mart's Q3 revenue grew by 245%-250% year-on-year, with significant contributions from both domestic and international markets [27]. Consumer Behavior Trends - The report indicates that sales of products related to the "trade-in" program are growing rapidly, with retail sales of communication equipment, furniture, and cultural office supplies increasing by 16.2%, 16.2%, and 6.2%, respectively [21].

Core Insights - The report highlights the ongoing recovery in the A-share market, with structural opportunities emerging in various sectors, particularly technology and energy [14][15][16] - The report emphasizes the importance of long-term capital in enhancing market stability and supporting high-quality development in the capital market [11][12] Domestic Market Performance - The Shanghai Composite Index closed at 3,950.31, with a daily increase of 0.71%, while the Shenzhen Component Index rose by 2.02% to 13,289.18 [4] - The average price-to-earnings (P/E) ratios for the Shanghai Composite and ChiNext Index are 16.02 and 48.28, respectively, indicating a favorable environment for medium to long-term investments [13][15] International Market Performance - The Dow Jones Industrial Average closed at 30,772.79, down 0.67%, while the S&P 500 and Nasdaq also experienced declines of 0.45% and 0.15%, respectively [5] Industry Analysis - The report notes a significant decline in the media sector, with a 6.65% drop in the media index from September 29 to October 22, underperforming compared to the broader market indices [19] - The automotive industry achieved record production and sales figures in September, with production reaching 3.28 million vehicles and sales at 3.23 million, marking year-on-year increases of 17.15% and 14.86% respectively [24][25] - The new energy vehicle penetration rate reached 49.72% in September, reflecting strong growth in this segment [24] Technology and AI Developments - The report discusses advancements in AI applications, particularly the release of OpenAI's latest video generation model, which enhances the capabilities of AI in content creation [22] - The software industry in China saw a revenue increase of 12.6% year-on-year in the first eight months of 2025, indicating a robust growth trajectory [26] Investment Recommendations - The report suggests focusing on sectors such as gaming, which is expected to benefit from favorable policies and strong market demand, as well as the publishing sector, which offers stable returns due to its low volatility and high dividend yields [21][25] - In the automotive sector, the report recommends attention to companies that are well-positioned to benefit from the ongoing transition to smart and electric vehicles [25]

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][28]. Core Insights - The report highlights significant market movements, with the retail trade, social services, and beauty care sectors showing varied performance, ranking 19th, 27th, and 25th respectively among 31 primary industries during the week of September 8-12, 2025 [14][16]. - Key events include Huaxi Biological's strategic investment in Saint Pharma, which focuses on small nucleic acid drugs, and Jinbo Biological's approval for a new injectable collagen product [3][23]. - The report notes a substantial increase in domestic and international flight searches ahead of the Mid-Autumn Festival and National Day holidays, indicating a recovery in travel demand [4][24]. Summary by Sections 1. Weekly Market Review - The retail trade sector increased by 0.85%, while social services and beauty care sectors decreased by 0.28% and 0.23% respectively, compared to the Shanghai Composite Index's increase of 1.52% [14][16]. 2. Key Industry Data and News - The Chinese government allocated 100 billion yuan for childcare subsidies and plans to gradually implement free preschool education [3][23]. - Huaxi Biological invested approximately 138 million HKD in Saint Pharma, acquiring a 9.44% stake, while Jinbo Biological's new collagen product is the first of its kind to enter the pharmaceutical excipient market [23][24]. 3. Key Company Announcements - Jinbo Biological announced management changes, with founder Yang Xia appointed as CEO, and plans for a cash acquisition by Langzi Co. for a controlling stake in a cosmetic surgery hospital [27][28]. 4. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzi Biological, and Marumi Biological, among others, as potential investment opportunities in the beauty care and new consumption sectors [5][28].

Investment Rating - The industry maintains a "Recommended" rating, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][32]. Core Insights - The report highlights a significant performance increase in the retail, social services, and beauty care sectors, with respective weekly gains of +4.55%, +4.55%, and +5.35%, outperforming the Shanghai Composite Index [2][13]. - Key companies in the beauty care sector reported mixed results, with some showing declines in revenue while others experienced growth, indicating a varied recovery across the industry [3][23][28]. - The IP derivatives segment, particularly Bubble Mart, demonstrated exceptional growth with a 204.4% increase in revenue year-on-year, showcasing strong market demand for collectible products [25][26]. Summary by Sections Market Performance - The retail, social services, and beauty care sectors ranked 8th, 9th, and 5th respectively among 31 primary industries during the week of August 18-22, 2025, with notable increases in sub-sectors like internet e-commerce, education, and cosmetics [2][13][15]. Key Industry Data and News - Beauty Care: Estee Lauder reported a net sales decline of 8% for the fiscal year 2025, with a notable recovery in the Chinese market, achieving net sales of $2.741 billion [23]. - Travel Chain: Xiangyuan Culture achieved a revenue increase of 35.41% in H1 2025, indicating a strong recovery in tourism [4][28]. - IP Derivatives: Bubble Mart's revenue reached 13.88 billion yuan in H1 2025, a 204.4% increase, with significant contributions from various regions [25][26]. Company Announcements - Lao Pu Gold reported a revenue of 12.354 billion yuan in H1 2025, a 251.0% increase, with a net profit growth of 285.8% [27]. - Shanghai Jahwa achieved a revenue of 3.478 billion yuan, growing by 4.75%, with a net profit increase of 11.66% [30]. - Marubi Biological reported a revenue of 1.769 billion yuan, a 30.83% increase, with a net profit growth of 5.21% [30]. Investment Recommendations - The report suggests focusing on companies such as Shangmei, Juzi Biological, Marubi Biological, Runben, Proya, Chaohongji, Buluko, and Furida as potential investment targets within the recommended sectors [6][32].